Beclomethasone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 5 EU WC, 3 KDMF, 11 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

163 FDF Dossiers, 14 FDA Orange Book, 91 Europe, 7 Canada, 4 Australia, 14 South Africa, 33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 15 Solubilizers, 14 Direct Compression, 10 Co-Processed Excipients, 7 Parenteral, 6 Controlled & Modified Release, 6 Disintegrants & Superdisintegrants, 5 Granulation, 5 Rheology Modifiers, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Taste Masking, 3 Topical, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 2 Surfactant & Foaming Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 79 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

52 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19389 / DOSAGE - SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BECLOMETHASONE DIPROPIONATE MONOHYDRATE(UNII: 4H7L9AI22I) (BECLOMETHASONE - UNII:KGZ1SLC28Z)	BECLOMETHASONE	42ug

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
DEXTROSE(IY9XDZ35W2)
PHENYLETHYL ALCOHOL(ML9LGA7468)
POLYSORBATE 80(6OZP39ZG8H)

Drug Product Composition: Beclomethasone

Beclomethasone

Beclomethasone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

18 USDMF

12 CEP/COS

2 JDMF

5 EU WC

3 KDMF

11 NDC API

30 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FINISHED DOSAGE FORMULATIONS

163 FDF Dossiers

14 FDA Orange Book

91 Europe

7 Canada

4 Australia

14 South Africa

33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

1 DKSH

1 Jai Radhe Sales

6 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

4 Kerry

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

16 Thickeners and Stabilizers

15 Solubilizers

14 Direct Compression

10 Co-Processed Excipients

7 Parenteral

6 Controlled & Modified Release

6 Disintegrants & Superdisintegrants

5 Granulation

5 Rheology Modifiers

4 Coating Systems & Additives

4 Film Formers & Plasticizers

3 Taste Masking

3 Topical

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons